{
  "meta": {
    "title": "Integrated_Mini_Test_6_-_Pharmacology",
    "url": "https://brainandscalpel.vercel.app/integrated-mini-test-6-pharmacology-40e52bd9.html",
    "scrapedAt": "2025-11-30T12:47:21.965Z"
  },
  "questions": [
    {
      "text": "1. A 16-year-old female patient presented with primary amenorrhea and short stature. You notice the below characteristic finding in her. Which of the following drugs is likely to benefit this patient's short stature?",
      "choices": [
        {
          "id": 1,
          "text": "Bromocriptine"
        },
        {
          "id": 2,
          "text": "Cabergoline"
        },
        {
          "id": 3,
          "text": "Somatropin"
        },
        {
          "id": 4,
          "text": "Pegvisomant"
        }
      ],
      "correct_choice_id": 3,
      "solution": "The given clinical scenario and the image showing a webbed neck are characteristic of Turner syndrome and somatropin is likely to benefit this child's short stature.<br><br>Somatropin refers to the growth hormone (GH) preparations that match the native GH. FDA-approved indications for growth hormone (GH) treatment include growth hormone deficiency, Turner Syndrome, chronic renal failure before transplantation, small for gestational age / short stature, idiopathic short stature, Noonan syndrome, Prader-Willi Syndrome, AIDS-related wasting, and malabsorption associated with the short-bowel syndrome.<br><br>It can cause adverse effects such as pseudotumor cerebri (idiopathic intracranial hypertension), type 2 diabetes mellitus, carpal tunnel syndrome, slipped capital femoral epiphysis, and transient gynecomastia. GH therapy is contraindicated in patients with acute critical illness, active malignancy, and non-proliferative and proliferative retinopathy.<br><br>Other growth hormone agonists that can be used are mecasermin (recombinant insulin-like growth factor 1) and tesamorelin (GH-releasing hormone).<br><br>Turner syndrome (45, XO) is a mendelian disorder characterized by ovarian dysgenesis, lymphedema, web neck and short stature.<br><br>Other options: <br><br>Options A & B: Bromocriptine and cabergoline are dopamine receptor agonists that are used in patients with prolactinomas.<br><br>Option D: Pegvisomant is a GH-receptor antagonist that is used to treat acromegaly.<br><br>Pearl PM2182: Disorders of Sexual Development<br><br><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Complete androgen insensitivity</strong></p>\n</td>\n<td>\n<p><strong>Mullerian agenesis</strong></p>\n</td>\n<td>\n<p><strong>Turner syndrome</strong></p>\n</td>\n<td>\n<p><strong>Complete XY dysgenesis (Swyer syndrome)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cause</strong></p>\n</td>\n<td>\n<p>X-linked mutation of androgen receptor</p>\n</td>\n<td>\n<p>Hypoplastic or absent Mullerian ductal system</p>\n<p><strong>Also called Mayer-Rokitansky-Küster-Hauser syndrome</strong></p>\n</td>\n<td>\n<p>Complete or partial absence of one X chromosome</p>\n</td>\n<td>\n<p>SRY gene mutation on the Y chromosome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Reproductive organs</strong></p>\n</td>\n<td>\n<p>Absent uterus and upper vagina, cryptorchid testis</p>\n</td>\n<td>\n<p>Absent or rudimentary uterus and upper vagina, normal ovaries</p>\n</td>\n<td>\n<p>Normal uterus and vagina, streak gonads</p>\n</td>\n<td>\n<p>Normal uterus and vagina, streak gonads</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Breast</strong></p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n<td>\n<p>Variable</p>\n</td>\n<td>\n<p>No</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Axillary/</strong><strong>Pubic hair</strong></p>\n</td>\n<td>\n<p>Minimal to absent</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Minimal to absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Karyotype</strong></p>\n</td>\n<td>\n<p>46 XY</p>\n</td>\n<td>\n<p>46 XX</p>\n</td>\n<td>\n<p>45 XO or </p>\n<p>45 X mosaicism</p>\n</td>\n<td>\n<p>46 XY</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br> <br><br>Note: <br><br>Turner's syndrome have different chromosomal anomalies:<br><br>* 45 XO which is seen in 40-50% patients <br><br>* 45 X mosaicism (eg, 45,X/46,XX or 45,X/47,XXX, or 45,X mosaics with the X chromosome anomalies)",
      "explanation_video": "",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e03dbd4e23214adc8958ecef55f01b7e.JPEG"
      ],
      "explanation_images": []
    },
    {
      "text": "2. Patients taking which of the following drugs should be advised to avoid drinking grapefruit juice?",
      "choices": [
        {
          "id": 1,
          "text": "Aspirin"
        },
        {
          "id": 2,
          "text": "Pravastatin"
        },
        {
          "id": 3,
          "text": "Losartan"
        },
        {
          "id": 4,
          "text": "Atorvastatin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "Patients taking Atorvastatin should be advised to avoid drinking grapefruit juice.<br><br>It is because grapefruit juice inhibits CYP3A4 in the liver, particularly at high doses, leading to decreased drug elimination via hepatic metabolism and can increase potential drug toxicities. Atorvastatin is metabolized via this pathway.<br><br><table>\n<tbody>\n<tr>\n<td>\n<p><strong><span class=\"ALqaynuk\">CYP4</span><span class=\"amBRRcHR\">50</span> <span class=\"ygmDVSTb\">enzy</span><span class=\"yMDKvSGO\">me</span> <span class=\"mIXDVwEo\">ind</span><span class=\"pZjrThPQ\">ucer</span><span class=\"tdCvhTUW\">s</span></strong></p>\n</td>\n<td><strong><span class=\"pNtsSTpJ\">CYP</span> <span class=\"VvMNUiJj\">450</span> <span class=\"ETVAktHw\">enzy</span><span class=\"FLdbGije\">me</span> <span class=\"IGuWwlFT\">inhi</span><span class=\"HKMkPTgn\">bit</span><span class=\"lqRVdEZM\">or</span><span class=\"oYMHBFCA\">s</span></strong></td>\n</tr>\n<tr>\n<td><span class=\"HxsvDrvL\">Ca</span><span class=\"ISpGiBXB\">rbam</span><span class=\"Gysuemtn\">az</span><span class=\"FyvZJMaT\">epi</span><span class=\"hqTReUsU\">ne</span><br/><span class=\"ZOewileB\">Cig</span><span class=\"znpMZFAw\">aret</span><span class=\"MQGuvVDk\">te</span> <span class=\"aeNhLbdv\">smok</span><span class=\"LwRIUJCF\">ing</span><br/><span class=\"XqxOVHbT\">Ri</span><span class=\"HxsvDrvL\">famp</span><span class=\"cmgMAreI\">icin</span><br/><span class=\"fAiaXuEj\">Al</span><span class=\"pAXljGfn\">coho</span><span class=\"fAiaXuEj\">l</span> <span class=\"oYMHBFCA\">(ch</span><span class=\"lqRVdEZM\">roni</span><span class=\"aeNhLbdv\">c)</span><br/><span class=\"fRhiyPVi\">Phen</span><span class=\"GInoNlXE\">yto</span><span class=\"ALqaynuk\">in</span><br/><span class=\"NqpVOhcc\">Phen</span><span class=\"GjQEJcdy\">ob</span><span class=\"xqgbiaXM\">ar</span><span class=\"Gysuemtn\">bito</span><span class=\"fpQDnKnK\">ne</span></td>\n<td>\n<p><span class=\"pqKxGEPv\">Sodi</span><span class=\"ALqaynuk\">um</span> <span class=\"NNivOLUP\">valp</span><span class=\"XShwIRKX\">roat</span><span class=\"btyDcgLD\">e</span><br/><span class=\"pQhHwGXq\">SSRI</span><span class=\"hqTReUsU\">s</span> <span class=\"NNivOLUP\">-</span> <span class=\"mIXDVwEo\">fluo</span><span class=\"lqRVdEZM\">xeti</span><span class=\"KjSPhIkH\">ne,</span> <span class=\"tdCvhTUW\">fluv</span><span class=\"pAXljGfn\">ox</span><span class=\"igSUesjE\">ami</span><span class=\"JzwAMGgY\">ne</span><span class=\"ALqaynuk\">,</span> <span class=\"fRhiyPVi\">par</span><span class=\"pqKxGEPv\">oxet</span><span class=\"xOgJOcFK\">ine</span><span class=\"xOgJOcFK\">,</span> <span class=\"pNtsSTpJ\">ser</span><span class=\"cmgMAreI\">tr</span><span class=\"NfjIqkvj\">al</span><span class=\"fpQDnKnK\">in</span><span class=\"YVBlTPLW\">e</span><br/><span class=\"RLvLjmEv\">Azol</span><span class=\"UlMETZCD\">e</span> <span class=\"znpMZFAw\">ant</span><span class=\"NfjIqkvj\">ifu</span><span class=\"qUUOvVdp\">ngal</span><span class=\"FLdbGije\">s-ke</span><span class=\"AAekkUUY\">toco</span><span class=\"pNtsSTpJ\">nazo</span><span class=\"hqTReUsU\">le</span><span class=\"XShwIRKX\">,</span> <span class=\"atZZpKiN\">it</span><span class=\"ygmDVSTb\">ra</span><span class=\"TNIdVOfH\">co</span><span class=\"SzwPiHzm\">na</span><span class=\"cmgMAreI\">zol</span><span class=\"LwRIUJCF\">e,</span> <span class=\"yBNYeaXz\">fl</span><span class=\"nKoufjjz\">uco</span><span class=\"JzwAMGgY\">nazo</span><span class=\"TNIdVOfH\">le</span><br/><span class=\"MdWLYFXT\">Er</span><span class=\"pqKxGEPv\">ythr</span><span class=\"CrIGJpzn\">omyc</span><span class=\"yBNYeaXz\">in,</span> <span class=\"fbqITKss\">cla</span><span class=\"fAiaXuEj\">rith</span><span class=\"FyvZJMaT\">ro</span><span class=\"kHJoHnfc\">myc</span><span class=\"mjeWQZGw\">in</span><br/><span class=\"cmgMAreI\">Cipr</span><span class=\"DzxjaAel\">of</span><span class=\"NwHbbENL\">lox</span><span class=\"giMKYyGh\">acin</span><br/><span class=\"qUUOvVdp\">Omep</span><span class=\"JzwAMGgY\">ra</span><span class=\"zPFRherg\">zol</span><span class=\"JzwAMGgY\">e</span><br/><span class=\"lqRVdEZM\">Gra</span><span class=\"TNIdVOfH\">pe</span><span class=\"ETVAktHw\">frui</span><span class=\"yMDKvSGO\">t</span> <span class=\"pqKxGEPv\">ju</span><span class=\"NqpVOhcc\">ic</span><span class=\"wzshCCzs\">e</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>Other options:<br><br>Option A: Aspirin is cleared via renal mechanisms.<br><br>Option B: Pravastatin is not metabolized to any appreciable extent by the CYP system and is excreted unchanged in the urine. However, other HMG-CoA reductase inhibitors like lovastatin, simvastatin are metabolized via CYP3A4.<br><br>Option C: Losartan is metabolised by CYP2C9.<br><br>Pearl PM2368: Metabolism of drugs<br><br>Drugs metabolized by cyp3A4 enzymes:<br><br>* Protease inhibitors<br><br>* Statins<br><br>* Benzodiazepines<br><br>* Amiodarone<br><br>* Estrogen<br><br>* Erythromycin",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "3. A 30-year-old woman with depression is on sertraline and has complaints of a chronic cough. She takes some over-the-counter pills to relieve her symptoms. Four days later, she is brought to the ER with complaints of altered sensorium, diarrhea, and abdominal cramps. On examination, her pulse rate was 125/min, BP was 170/100 mmHg. Bilateral hyper-reflexia and ankle clonus were also noted. Which of the following drugs did she most likely consume that led to this presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Codeine"
        },
        {
          "id": 2,
          "text": "Guaifenecin"
        },
        {
          "id": 3,
          "text": "Bromhexine"
        },
        {
          "id": 4,
          "text": "Dextromethorphan"
        }
      ],
      "correct_choice_id": 4,
      "solution": "The above clinical scenario is suggestive of serotonin syndrome. Dextromethorphan is the antitussive that is likely to have caused her symptoms. <br><br>Serotonin syndrome occurs when a combination of drugs that increase serum serotonin levels, like MAOIs (monoamine oxidase inhibitors), SSRIs (selective serotonin reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake inhibitors), TCAs (tricyclic antidepressants), tramadol, ondansetron, triptans, linezolid, MDMA (amphetamine), dextromethorphan, etc, is used. <br><br>In this patient, the combination of Sertraline, an SSRI & Dextromethorphan, an NMDA Antagonist antitussive agent, results in a serotonin surge.<br><br>It is characterised by features:<br><br>* Autonomic instability - hyperthermia, hypertension, tachycardia, diaphoresis, vomiting, diarrhea.<br><br>* Altered mental status - agitation, confusion, delirium.<br><br>* Neuromuscular hyperactivity - tremor, hyperreflexia, myoclonus.<br><br>It is treated with cyproheptadine (5-HT2 receptor antagonist). <br><br>Other options:<br><br>Codeine, Guaifenecin & Bromhexine do not have MAOI effects. They do not cause serotonin syndrome when combined with a serotonergic antidepressant.<br><br>Pearl PM2057: Psychiatric emergency: Fever with altered mental status<br><br>In a clinical setting of fever with altered mental status, it is important to differentiate between the following.<br><br><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong> Syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Neuroleptic malignant syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Serotonin syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Anticholinergic syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Malignant hyperthermia</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong> Cause</strong></span></div>\n</td>\n<td>\n<div><span>Dysregulation of dopaminergic pathways</span></div>\n</td>\n<td>\n<div><span>Co-prescription of MAO-I and SSRIs leading to increased serotonin and norepinephrine levels</span></div>\n</td>\n<td>\n<div>\n<div><span>Anticholinergic i</span><span>ntoxication</span></div>\n</div>\n</td>\n<td>\n<div>\n<div><span>Halogenated anesthetics and succinylcholine leading to a</span></div>\n</div>\n<div><span>hypermetabolic response causing an increased intracellular calcium level</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Fever and altered mental status</strong></span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Muscle tone</strong></span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n<td>\n<div><span><strong>Normal</strong></span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Skin and mucosa</strong></span></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n<td>\n<div><strong><span>Dry</span></strong></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Pupils</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span><strong>Dilated</strong></span></div>\n</td>\n<td>\n<div><span><strong>Dilated</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Bowel sounds</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span>Increased</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Reflexes</strong></span></div>\n</td>\n<td>\n<div><span>Bradyreflexia</span></div>\n</td>\n<td>\n<div><span>Increased</span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n<td>\n<div><span>Stop antipsychotic;</span></div>\n<div><span>give dantrolene, bromocriptine and </span><span>monitor CPK levels</span></div>\n</td>\n<td>\n<div><span>Change the drug; </span></div>\n<div><span>give cyproheptadine</span></div>\n</td>\n<td>\n<div><span>Discontinue drug;</span></div>\n<div><span>give i.v. physostigmine</span></div>\n</td>\n<td>\n<div><span>Cooling, dantrolene, insulin, and glucose</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "4. A 30-year-old woman presents to the OPD with nicotine addiction. She is a known case of epilepsy and is on medication. She was also recently diagnosed with panic disorder. Which of the following drugs should not be prescribed to her?",
      "choices": [
        {
          "id": 1,
          "text": "Varenicline"
        },
        {
          "id": 2,
          "text": "Nortriptyline"
        },
        {
          "id": 3,
          "text": "Clonidine"
        },
        {
          "id": 4,
          "text": "Bupropion"
        }
      ],
      "correct_choice_id": 4,
      "solution": "Bupropion should not be prescribed to her as she is a known case of epilepsy and panic disorder. Bupropion is avoided in patients with seizure disorder as it lowers the seizure threshold. It is also avoided in patients with panic disorder and severe anxiety.<br><br>Cigarette smoking is the leading preventable cause of death worldwide. The FDA-approved drugs used in the treatment of tobacco dependence are varenicline, bupropion, and nicotine supplements. Clonidine, nortriptyline and cytisine are the second-line drugs used.<br><br>Bupropion is a first-line drug used for nicotine cessation and has the added benefit of causing weight loss. Weight gain is commonly seen after stopping nicotine use. Nicotine supplements are available in various forms - gums, lozenges, inhalers, nasal sprays, mouth sprays, and sublingual tablets. Combination therapy is always better than single therapy. Behavioural support and counselling play a major role along with drug therapy.<br><br><table>\n<tbody>\n<tr>\n<td><strong><span class=\"gQlNDmPM\">Drug</span></strong></td>\n<td><strong><span class=\"evOnKQrZ\">Me</span><span class=\"oIpTFaDW\">cha</span><span class=\"lzlFDUyT\">nis</span><span class=\"aclOjZWb\">m</span> <span class=\"LWbOreks\">of</span> <span class=\"evOnKQrZ\">act</span><span class=\"DFBHszGl\">ion</span></strong></td>\n<td><strong><span class=\"nvjBjHvh\">Ad</span><span class=\"FzcTuYrx\">vers</span><span class=\"UXBsgjvj\">e</span> <span class=\"VnKtJGOf\">effe</span><span class=\"ujrQAYpR\">cts</span></strong></td>\n</tr>\n<tr>\n<td><strong><span class=\"xlszArNs\">Nic</span><span class=\"qyUNSVsh\">oti</span><span class=\"WTuJCzpj\">ne</span> <span class=\"OOHUQvrR\">supp</span><span class=\"vVitWJzc\">leme</span><span class=\"QIBwzgmz\">nt</span><span class=\"OOHUQvrR\">s</span></strong></td>\n<td><span class=\"vzbFCWeN\">Act</span><span class=\"VnKtJGOf\">s</span> <span class=\"qrYDqvxY\">on</span> <strong><span class=\"FfSNLFNo\">al</span><span class=\"GiyURnRm\">ph</span><span class=\"RkmgvMtS\">a-</span><span class=\"nrTnUWxD\">4</span> <span class=\"nvjBjHvh\">beta</span><span class=\"ZVEkaDWK\">-2</span> <span class=\"WkBjBWlV\">re</span><span class=\"wiAVtcIH\">ce</span><span class=\"oIpTFaDW\">pt</span><span class=\"cUZDSRIe\">or</span><span class=\"MpTzbLlR\">s</span></strong> <span class=\"CWwvmOci\">in</span> <span class=\"xlszArNs\">the</span> <span class=\"GGqjTENf\">br</span><span class=\"okMSFlqG\">ai</span><span class=\"mMLWTxxR\">n</span></td>\n<td>\n<ul>\n<li><span class=\"okMSFlqG\">Pep</span><span class=\"nrTnUWxD\">tic</span> <span class=\"LWbOreks\">ulce</span><span class=\"GiyURnRm\">rs</span></li>\n<li><span class=\"tewkafBN\">Ab</span><span class=\"fuYsXTHj\">domi</span><span class=\"nVQHbJsg\">na</span><span class=\"ShoiFYMH\">l</span> <span class=\"qrYDqvxY\">pa</span><span class=\"RkmgvMtS\">in</span></li>\n<li><span class=\"MpTzbLlR\">Slee</span><span class=\"SPMokWJM\">p</span> <span class=\"TdptYyZl\">dist</span><span class=\"zrVxEffd\">urb</span><span class=\"dDyoAJkD\">an</span><span class=\"TpTBQDFm\">ce</span></li>\n<li><span class=\"aclOjZWb\">Dela</span><span class=\"QqSxMkUT\">ye</span><span class=\"uyPSbcWj\">d</span> <span class=\"UXBsgjvj\">woun</span><span class=\"qrwLnteq\">d</span> <span class=\"SPMokWJM\">hea</span><span class=\"SbxJnenU\">li</span><span class=\"pfObAxXh\">ng</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\"XAAuBlFm\">Bupr</span><span class=\"GGqjTENf\">opio</span><span class=\"HKefMevj\">n</span></strong></td>\n<td><span class=\"GRoWfght\">Inhi</span><span class=\"hnDIomMG\">bi</span><span class=\"XAAuBlFm\">ts</span> <span class=\"jvuEeBzx\">the</span> <span class=\"GBRZshOt\">re</span><span class=\"GSPJuczT\">upt</span><span class=\"WkBjBWlV\">ake</span> <span class=\"FfSNLFNo\">of</span> <span class=\"TIbBnxcT\">no</span><span class=\"nvjBjHvh\">radr</span><span class=\"OOHUQvrR\">enal</span><span class=\"okMSFlqG\">ine</span> &amp; <span class=\"yzYjHudF\">dop</span><span class=\"QqSxMkUT\">am</span><span class=\"cUZDSRIe\">ine</span> <span class=\"SPMokWJM\">in</span> <span class=\"HcZFuiIC\">the</span> <span class=\"SMuNyaLj\">brai</span><span class=\"pfObAxXh\">n</span></td>\n<td>\n<ul>\n<li><strong><span class=\"TdptYyZl\">Conv</span><span class=\"hnDIomMG\">uls</span><span class=\"CWwvmOci\">ions</span></strong></li>\n<li><strong><span class=\"fuYsXTHj\">Weig</span><span class=\"zdmIKbYa\">ht</span> <span class=\"okMSFlqG\">lo</span><span class=\"tNWoznpT\">ss</span></strong></li>\n<li><span class=\"qrwLnteq\">Dry</span> <span class=\"TdptYyZl\">mou</span><span class=\"mOLTNpOb\">th</span></li>\n<li><span class=\"dDyoAJkD\">Tre</span><span class=\"UXBsgjvj\">mors</span></li>\n<li><strong><span class=\"cUZDSRIe\">Psy</span><span class=\"OOHUQvrR\">ch</span><span class=\"aydhFCPp\">ot</span><span class=\"tewkafBN\">ic</span> <span class=\"SbxJnenU\">sy</span><span class=\"qyUNSVsh\">mpto</span><span class=\"GqWWxveD\">ms</span></strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\"dYnDaKHb\">Vare</span><span class=\"TpTBQDFm\">nicl</span><span class=\"zZCqoGUD\">ine</span></strong></td>\n<td><strong><span class=\"WkBjBWlV\">Part</span><span class=\"FXonoHWn\">ial</span> <span class=\"tNWoznpT\">ag</span><span class=\"nvjBjHvh\">onis</span><span class=\"TdptYyZl\">t</span></strong> <span class=\"RkmgvMtS\">at</span> <span class=\"xlszArNs\">alph</span><span class=\"aydhFCPp\">a-</span><span class=\"OOHUQvrR\">4</span> <span class=\"pagWsYNY\">beta</span><span class=\"tNWoznpT\">-2</span> <span class=\"fuYsXTHj\">ni</span><span class=\"HKefMevj\">coti</span><span class=\"pagWsYNY\">nic</span> <span class=\"QqSxMkUT\">rece</span><span class=\"mMLWTxxR\">pt</span><span class=\"biJetkcn\">ors</span></td>\n<td>\n<ul>\n<li><span class=\"RsmvELiu\">Inso</span><span class=\"GqWWxveD\">mnia</span></li>\n<li><span class=\"nvjBjHvh\">Ab</span><span class=\"xlszArNs\">norm</span><span class=\"FzcTuYrx\">al</span> <span class=\"XAAuBlFm\">drea</span><span class=\"tNWoznpT\">ms</span></li>\n<li><span class=\"GGqjTENf\">Ag</span><span class=\"dDyoAJkD\">grav</span><span class=\"GRDcunaE\">atio</span><span class=\"OOHUQvrR\">n</span> <span class=\"pjGpUURx\">of</span> <span class=\"vzbFCWeN\">neu</span><span class=\"GiyURnRm\">rops</span><span class=\"tNWoznpT\">yc</span><span class=\"vNxdPmZt\">hiat</span><span class=\"aclOjZWb\">ri</span><span class=\"HKefMevj\">c</span> <span class=\"fuYsXTHj\">sym</span><span class=\"yzYjHudF\">ptom</span><span class=\"CmpPvrqU\">s</span></li>\n<li><strong><span class=\"RsmvELiu\">Suic</span><span class=\"xXbagbGh\">idal</span> <span class=\"evOnKQrZ\">ide</span><span class=\"GRoWfght\">ati</span><span class=\"QqSxMkUT\">on</span></strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\"GSPJuczT\">Cl</span><span class=\"ujrQAYpR\">onid</span><span class=\"YudGBPyk\">ine</span></strong></td>\n<td><span class=\"rtvNeHoA\">Al</span><span class=\"qrYDqvxY\">ph</span><span class=\"SNKHSnMD\">a-2</span> <span class=\"eHDlFNRc\">adre</span><span class=\"VnKtJGOf\">nerg</span><span class=\"oIpTFaDW\">ic</span> <span class=\"qrYDqvxY\">agon</span><span class=\"okMSFlqG\">ist</span> <span class=\"TpTBQDFm\">de</span><span class=\"UXBsgjvj\">crea</span><span class=\"dYnDaKHb\">ses</span> <span class=\"evOnKQrZ\">symp</span><span class=\"CmpPvrqU\">ath</span><span class=\"zZCqoGUD\">et</span><span class=\"vVitWJzc\">ic</span> <span class=\"FfSNLFNo\">acti</span><span class=\"NrAJSlgK\">vity</span> <span class=\"mOLTNpOb\">in</span> <span class=\"TpTBQDFm\">the</span> <span class=\"aydhFCPp\">br</span><span class=\"UXBsgjvj\">ain</span></td>\n<td>\n<ul>\n<li><span class=\"VNNCTruI\">Dry</span> <span class=\"GqWWxveD\">mou</span><span class=\"zdmIKbYa\">th</span></li>\n<li><span class=\"TpTBQDFm\">Seda</span><span class=\"iMYLyHsq\">ti</span><span class=\"AiWmlZtc\">on</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\"fuYsXTHj\">Nort</span><span class=\"cSlTogZz\">ript</span><span class=\"QIBwzgmz\">ylin</span><span class=\"udTDSIBV\">e</span></strong></td>\n<td><span class=\"ujrQAYpR\">Inhi</span><span class=\"vNxdPmZt\">bi</span><span class=\"nrTnUWxD\">ts</span> <span class=\"qyUNSVsh\">the</span> <span class=\"iMYLyHsq\">reup</span><span class=\"DzXLWTPR\">take</span> <span class=\"nrTnUWxD\">of</span> <span class=\"YudGBPyk\">se</span><span class=\"nENMvuKg\">ro</span><span class=\"uyPSbcWj\">toni</span><span class=\"WkBjBWlV\">n</span> <span class=\"WTuJCzpj\">and</span> <span class=\"CWwvmOci\">nor</span><span class=\"yzYjHudF\">ep</span><span class=\"pagWsYNY\">inep</span><span class=\"tewkafBN\">hr</span><span class=\"CWwvmOci\">ine</span> <span class=\"TpTBQDFm\">in</span> <span class=\"VNNCTruI\">pre</span><span class=\"HKefMevj\">syna</span><span class=\"nENMvuKg\">ptic</span> <span class=\"ZVEkaDWK\">neur</span><span class=\"nVQHbJsg\">on</span><span class=\"cSlTogZz\">s</span></td>\n<td>\n<ul>\n<li><span class=\"okMSFlqG\">Dry</span> <span class=\"iMYLyHsq\">mout</span><span class=\"nENMvuKg\">h</span></li>\n<li><span class=\"QIBwzgmz\">Sed</span><span class=\"TIbBnxcT\">atio</span><span class=\"xXbagbGh\">n</span> </li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>Pearl PM0416: Substances of abuse<br><br><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Substance</strong></span></div>\n</td>\n<td>\n<div><span><strong>Withdrawal symptoms</strong></span></div>\n</td>\n<td>\n<div><span><strong>Intoxication features</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alcohol</strong></span></div>\n</td>\n<td>\n<div><span>Tremors, delirium, seizures</span></div>\n</td>\n<td>\n<div><span>Blackouts, nystagmus and slurring of speech</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>BZD</strong></span></div>\n</td>\n<td>\n<div><span>Tremors, insomnia, anxiety</span></div>\n</td>\n<td>\n<div><span>Lethargy and drowsiness.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Opioid/ Heroin</strong></span></div>\n</td>\n<td>\n<div><span>Diarrhea, yawning, mydriasis, lacrimation, piloerection, cold turkey phenomenon</span></div>\n</td>\n<td>\n<div><span>Euphoria, depressed mental status, miosis, respiratory depression, constipation.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Nicotine/ Tobacco</strong></span></div>\n</td>\n<td>\n<div><span>Increased appetite</span></div>\n</td>\n<td>\n<div><span>Shows a biphasic pattern. </span></div>\n<div><span>Early stimulatory symptoms of vomiting, hypertension and tachycardia. </span><span>Later depressive symptoms of hypotension and bradycardia.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Cannabis</strong></span></div>\n</td>\n<td>\n<div><span>Irritability, sweating, tremors, decreased appetite</span></div>\n</td>\n<td>\n<div><span>Increased appetite, euphoria, conjunctival injection, dry mouth, </span><span>panic, </span><span>synesthesia, impaired time perception, amotivational syndrome, run amok and </span><span>flashbacks.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Amphetamine</strong></span></div>\n</td>\n<td>\n<div><span>Depressed mood, suicidal thoughts, unpleasant dreams</span></div>\n</td>\n<td>\n<div>\n<div><span>Acute: </span><span>Sympathetic </span><span>overactivity, paranoid hallucinatory syndrome, violent behavior, psychosis and diaphoresis.</span></div>\n</div>\n<div><span>Chronic: Runs &amp; crashes, choreiform movements, tooth decay. Can resemble schizophrenia.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Cocaine</strong></span></div>\n</td>\n<td>\n<div><span>Depressed mood, suicidal thoughts</span></div>\n</td>\n<td>\n<div><span>Acute: Sympathetic overactivity, agitation, euphoria, chest pain, seizures and mydriasis</span></div>\n<div><span>Chronic: Cocaine psychosis (Magnan sign) and black pigmentation of the tongue.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>LSD/ Haluccinogen</strong></span></div>\n</td>\n<td>\n<div><span>Nothing significant</span></div>\n</td>\n<td>\n<div>\n<div><span>Synesthesia, brisk tendon reflex, t</span>achycardia, hypertension, panic, ataxia, visual hallucinations, euphoria and dysphoria.</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Phencyclidine (PCP)</strong></span></div>\n</td>\n<td>\n<div><span>Nothing significant </span></div>\n</td>\n<td>\n<div>Tachycardia, hypertension, ataxia, hallucinations, violent behavior, dissociation, amnesia and nystagmus.</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "5. A 68 year old heart failure patient with multiple co-morbidities was treated with a combination of the following drugs: chlorthalidone, furosemide, ramipril, acetazolamide, metoprolol, insulin and atorvastatin. Now he presents with right sided hearing loss. Examination shows Weber’s test localised to left ear and Rinne’s test shows ACBC in both ears. The most likely responsible offending agent acts in which part of the nephron?",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "3"
        },
        {
          "id": 3,
          "text": "2"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "The patient is suffering from sensorineural hearing loss. Among the given drugs, IV furosemide is the most likely offending agent causing ototoxicity used during heart failure treatment. Furosemide acts on the thick ascending limb of the loop of Henle which is marked by number 3 in the illustration.<br><br>Furosemide is a loop diuretic. It acts by inhibiting the Na+-K+-2Cl- symporter in the thick ascending limb of the loop of Henle, resulting in increased excretion of sodium, potassium, and chloride. Hypokalemia, hypocalcemia, hyperuricemia, and hypomagnesemia are the important side effects. <br><br>Other common ototoxic drugs are:<br><br>* Antibiotics like aminoglycosides ( gentamicin > tobramycin > amikacin > neomycin), erythromycin, and tetracyclines.<br><br>* Chemotherapeutic agents like cisplatin, bleomycin, and nitrogen mustard.<br><br>* High-dose aspirin, acetaminophen, and NSAIDs<br><br>* Antimalarials like quinine and quinidine<br><br>* Phosphodiesterase 5 inhibitors like sildenafil<br><br>Other options:<br><br>Option A: Carbonic anhydrase acts on the PCT(site 1). It is used for glaucoma, pseudotumor cerebri, metabolic alkalosis, and cystine stone prevention.<br><br>Option C: 2 represents the thin descending limb of the loop of Henle.<br><br>Option D: 4 represents the collecting duct. ADH receptor antagonists like Tolvaptan act in medullary CT. Used for treating hyponatremia.<br><br><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/01036f053f9a4ce7a4ace7fea5ebf6f3x1218x1600.JPEG\" alt=\"Explanation Image\"><br><br>Pearl PM0392: Site and mechanism of action of diuretics<br><br><table>\n<tbody>\n<tr>\n<td><span><strong>Diuretics </strong></span></td>\n<td><span><strong>Site of action  </strong></span></td>\n<td>\n<p><span><strong>Enzyme/receptor</strong><strong>/transporter inhibited </strong></span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Carbonic anhydrase inhibitors  </strong></span></td>\n<td><span>Proximal tubule  </span></td>\n<td><span>Carbonic anhydrase  </span></td>\n</tr>\n<tr>\n<td><span><strong>Loop diuretics </strong></span></td>\n<td><span>Thick ascending loop of Henle </span></td>\n<td><span>Na<sup>+</sup>- K<sup>+</sup>- 2Cl<sup>-</sup> symporter</span></td>\n</tr>\n<tr>\n<td><span><strong>Thiazides</strong></span></td>\n<td><span>Distal convoluted tubule </span></td>\n<td><span>Na<sup>+</sup>- Cl<sup>-</sup> symporter</span></td>\n</tr>\n<tr>\n<td><span><strong>Epithelial sodium channel inhibitors </strong></span></td>\n<td><span>Late distal tubule and collecting ducts  </span></td>\n<td><span>ENaC </span></td>\n</tr>\n<tr>\n<td><span><strong>Aldosterone antagonists </strong></span></td>\n<td><span>Late distal tubule and collecting ducts </span></td>\n<td><span>Mineralocorticoid receptors (indirectly ENaC) </span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>  <br><br><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1eebed7de1f34fd99539e6c7613f42f0x1280x1306.JPEG\" alt=\"Explanation Image\">",
      "explanation_video": "",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/40a6f9ea549c4a35bbe86501c4145d6b.JPEG"
      ],
      "explanation_images": []
    },
    {
      "text": "6. A 50-year-old male patient with HIV infection is started on antiretroviral therapy. After a few weeks of treatment, the patient develops severe abdominal pain radiating to the back, nausea, and elevated serum lipase levels. Which of the following antiretroviral drugs could be the potential cause of these symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Lamivudine"
        },
        {
          "id": 2,
          "text": "Nevirapine"
        },
        {
          "id": 3,
          "text": "Didanosine"
        },
        {
          "id": 4,
          "text": "Tenofovir"
        }
      ],
      "correct_choice_id": 3,
      "solution": "The given clinical scenario points towards pancreatitis which is a characteristic adverse effect of didanosine.<br><br>Didanosine (ddl) is an anti-retroviral drug belonging to the class of nucleoside reverse transcriptase inhibitor (NRTI). It is a synthetic analog of deoxyadenosine. The major clinical toxicities associated with didanosine therapy are peripheral distal sensory neuropathy and dose-dependent pancreatitis. Therefore, co-administration with drugs or conditions that increase the risk of either has to be avoided.<br><br>Other reported adverse effects include diarrhea, hepatitis, esophageal ulceration, cardiomyopathy, central nervous system toxicity (headache, irritability, insomnia), and hypertriglyceridemia.<br><br>Lamivudine and Tenofovir also belong to the class of NRTI while Nevirapine belong to the class of non nucleoside reverse transcriptase inhibitor (NNRTI). (option A, B and D)<br><br>Lamivudine can cause nausea, headache, fatigue, anemia, neutropenia, and lactic acidosis. Tenofovir can cause renal toxicity and a decrease in bone mineral density. Its safety profile is unknown in age less than 10 years and weights less than 30 kg. The key side effect of Nevirapine is hepatotoxicity.<br><br>Pearl PM1985: Drugs causing acute Pancreatitis<br><br> <br><br><table>\n<tbody>\n<tr>\n<td><strong> Group</strong></td>\n<td><strong> Examples</strong></td>\n</tr>\n<tr>\n<td>Angiotensin-converting enzyme inhibitors</td>\n<td>\n<p>Captopril</p>\n<p>Lisinopril</p>\n<p>Enalapril</p>\n</td>\n</tr>\n<tr>\n<td>Angiotensin receptor inhibitor</td>\n<td> Losartan</td>\n</tr>\n<tr>\n<td>Antimicrobial</td>\n<td>\n<p>Erythromycin</p>\n<p>Isoniazid</p>\n<p>Metronidazole</p>\n<p>Sulfamethazine</p>\n<p>Sulfamethoxazole</p>\n<p>Tetracycline</p>\n<p>Dapsone</p>\n</td>\n</tr>\n<tr>\n<td>Antithyroid</td>\n<td> Carbimazole</td>\n</tr>\n<tr>\n<td>H2 blocker</td>\n<td>\n<p>Cimetidine</p>\n</td>\n</tr>\n<tr>\n<td>Antipsychotics</td>\n<td> Clozapine</td>\n</tr>\n<tr>\n<td>Antiepileptic</td>\n<td>\n<p>Valproic acid</p>\n</td>\n</tr>\n<tr>\n<td>Steroids </td>\n<td>\n<p>Dexamethasone</p>\n<p>Hydrocortisone</p>\n</td>\n</tr>\n<tr>\n<td>Diuretics </td>\n<td>\n<p>Furosemide</p>\n<p>Hydrochlorothiazide</p>\n</td>\n</tr>\n<tr>\n<td>Lipid-lowering drugs </td>\n<td>\n<ul>\n<li>Simvastatin</li>\n<li>Fluvastatin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hormones</td>\n<td>\n<ul>\n<li>Estrogen </li>\n<li>Stibogluconate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Anticancer drugs</td>\n<td>\n<ul>\n<li>5-Aminosalicylic acid compounds</li>\n<li>L-Asparaginase</li>\n<li>Azathioprine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Others</td>\n<td>\n<p>Acetaminophen</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>Pearl PM1625: Causes of Acute Pancreatitis<br><br>Common causes<br><br>* Gallstones - most common<br><br>* Alcohol<br><br>* Post-ERCP (Endoscopic retrograde cholangiopancreatography)<br><br>* Blunt trauma, abdomen<br><br>* Post-operative (cardiothoracic, upper gastrointestinal, biliary)<br><br>* Hypertriglyceridemia<br><br>* Sphincter of Oddi dysfunction<br><br>Uncommon causes<br><br>* Hyperparathyroidism<br><br>* Hypercalcemia<br><br>* Deficiency of apolipoprotein CII<br><br>* Pancreas divisum<br><br>* Periampullary diverticulum<br><br>* Vasculitis<br><br>* Thrombotic thrombocytopenic purpura (TTP)<br><br>* Connective tissue disorders<br><br>* Ischemic–hypoperfusion states<br><br>* Hereditary pancreatitis<br><br>* Cystic fibrosis<br><br>* Renal failure<br><br>Drugs<br><br>* L-Asparaginase<br><br>* Steroids<br><br>* Sulfonamides<br><br>* Tetracycline<br><br>* Valproate<br><br>* Azathioprine<br><br>* Anti-retroviral drugs<br><br>* Estrogens<br><br>* Thiazide diuretics<br><br>Rare causes<br><br>* Autoimmune<br><br>* Infections (mumps, coxsackie B, cytomegalovirus, parasite)<br><br>* Malnutrition<br><br>* Scorpion bite",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "7. A 50-year-old patient with a recent history of MI and hypercholesterolemia as given in the report below was started on a hypolipidemic drug. Soon after, he developed muscle weakness. Which of the following statements is true regarding the action of the drug?<br><br>* LDL - 125 mg/dl<br><br>* HDL - 33 mg/dl<br><br>* TGL - 270 mg/dl<br><br>MI- myocardial infarction\nLDL- low-density lipoprotein\nHDL- high-density lipoprotein\nTGL- triglycerides",
      "choices": [
        {
          "id": 1,
          "text": "Decrease intestinal absorption of cholesterol"
        },
        {
          "id": 2,
          "text": "Inhibit cholesterol synthesis"
        },
        {
          "id": 3,
          "text": "Increase the activity of lipoprotein lipase"
        },
        {
          "id": 4,
          "text": "Increase hepatic conversion of cholesterol to bile acids"
        }
      ],
      "correct_choice_id": 2,
      "solution": "The hypolipidemic drug that was prescribed after an episode of myocardial infarction and has resulted in muscular weakness is most probably a statin. The correct statement regarding the action of statins is that they act by inhibiting cholesterol synthesis. <br><br>Statins are the most commonly used hypolipidemic drugs. Statins act by inhibiting the rate-limiting HMG-CoA reductase enzyme, which in turn inhibits cholesterol synthesis. They decrease low-density lipoproteins (LDL) and triglycerides and increase high-density lipoproteins in plasma.<br><br>Statins are used for secondary prophylaxis in patients who have already had an MI. Examples of statins - Lovastatin, Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin, and Pitavastatin.<br><br>Side effects of statins include myopathy and hepatotoxicity, which are common with the concurrent use of nicotinic acid, gemfibrozil, or CYP3A4 inhibitors.<br><br>Other options:<br><br>Option A: Ezetimibe decreases intestinal absorption of cholesterol.<br><br>Option C: Fibric acid derivatives increase the activity of lipoprotein lipase and decrease the release of fatty acids from adipose tissue. They, along with statins, cause myopathy. Fibrates are used to decrease very high triglycerides, which is not the case here. Moreover, post-MI statins are the preferred drug.<br><br>Option D: Bile acid sequestrants decrease the absorption of bile acids, increase hepatic conversion of cholesterol to bile acids, and decrease LDL receptors on hepatocytes.",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "8. A 17-year-old student comes to the clinic with a history of four episodes of arthritis involving large joints and was recently admitted for new-onset atrial fibrillation. A holosystolic murmur with early diastolic rumbling is heard at the apex. An early diastolic murmur is also heard at the right second intercostal space near the sternal edge. Which of the following is recommended for long-term prophylaxis of the likely underlying condition?",
      "choices": [
        {
          "id": 1,
          "text": "Glucocorticoids"
        },
        {
          "id": 2,
          "text": "Monthly penicillin G injections"
        },
        {
          "id": 3,
          "text": "Daily doxycycline"
        },
        {
          "id": 4,
          "text": "Daily aspirin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "The patient has clinical features and a history suggestive of recurrent episodes of acute rheumatic fever (ARF). Monthly penicillin G injections are recommended for long-term prophylaxis.<br><br>The findings of mitral regurgitation and aortic regurgitation indicate the diagnosis of ARF. The presence of atrial fibrillation indicates severe rheumatic heart disease. Prophylaxis with either oral phenoxymethylpenicillin (250 mg twice daily) or preferably, benzathine benzylpenicillin (1.2 million U IM monthly) is considered the best method to prevent further episodes of ARF, and therefore prevent further valvular damage.<br><br>ARF is an autoimmune disease that develops in response to group A streptococcal infection. It is commonly seen in children between the age of 5-14 years. An upper respiratory tract infection with some M serotypes of the organism is the trigger. The concept of molecular mimicry is used to explain the pathogenesis of the condition. <br><br>Since one attack of ARF increases the risk for further episodes and development of RHD, secondary prophylaxis is recommended by the American heart association (AHA)<br><br>Symptoms usually present after a latent period of about three weeks. Indolent carditis and chorea are the exceptions that can present even six months later. Migratory asymmetric polyarthritis which affects large joints and high-grade fever are common features. Cutaneous manifestations include erythema marginatum and subcutaneous nodules. Sydenham's chorea is commonly found in females and frequently affects the head and upper limbs.<br><br>Other options:<br><br>Option A: Glucocorticoids are recommended at a dose of 1–2 mg/kg per day (maximum, 80 mg), usually for a few days or up to a maximum of 3 weeks.<br><br>Option C: Doxycycline is not a first-line agent for group A Streptococcus, the pathogen that causes ARF.<br><br>Option D: Daily aspirin is the treatment of choice for the migratory arthritis of large joints and fever which are common manifestations of ARF.<br><br>Pearl PM2066: Revised Jones criteria for diagnosis of Acute Rheumatic Fever (ARF)<br><br>Revised Jones criteria for the diagnosis of rheumatic fever are as follows:<br><br><table>\n<tbody>\n<tr>\n<td colspan=\"2\">Major criteria</td>\n</tr>\n<tr>\n<td><strong>Low-risk populations*</strong></td>\n<td><strong>Moderate- and high-risk populations*</strong></td>\n</tr>\n<tr>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>Carditis- Clinical or subclinical</td>\n<td>Carditis- Clinical or subclinical</td>\n</tr>\n<tr>\n<td>Arthritis- <strong>Polyarthritis only</strong></td>\n<td>Arthritis- <strong>P</strong><strong>olyarthritis/polyarthralgia/monoarthritis</strong></td>\n</tr>\n<tr>\n<td>Chorea</td>\n<td>Chorea</td>\n</tr>\n<tr>\n<td>Erythema marginatum</td>\n<td>Erythema marginatum</td>\n</tr>\n<tr>\n<td>Subcutaneous nodules</td>\n<td>Subcutaneous nodules</td>\n</tr>\n<tr>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td colspan=\"2\">Minor criteria </td>\n</tr>\n<tr>\n<td><strong>Polyarthralgia</strong></td>\n<td><strong>Monoarthralgia</strong></td>\n</tr>\n<tr>\n<td>Fever (≥38.5°C)</td>\n<td>Fever (≥38°C)</td>\n</tr>\n<tr>\n<td>ESR ≥60 mm in the first hour and/or CRP ≥3.0 mg/dL</td>\n<td>ESR ≥30 mm/hr and/or CRP ≥3.0 mg/dL</td>\n</tr>\n<tr>\n<td><strong>Prolonged PR interval</strong>, after accounting for age variability (unless carditis is a major criterion)</td>\n<td>Prolonged PR interval, after accounting for age variability (unless carditis is a major criterion) </td>\n</tr>\n<tr>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td colspan=\"2\">For all patient populations with evidence of preceding Group A Streptococcal infection:(Increased ASLO/ anti-DNAse B titer or positive throat culture for group A streptococcus or positive rapid streptococcal carbohydrate antigen test) </td>\n</tr>\n<tr>\n<td>Diagnosis of initial ARF</td>\n<td>2 Major criteria or 1 major plus 2 minor criteria</td>\n</tr>\n<tr>\n<td>Diagnosis of recurrent ARF</td>\n<td>2 Major or 1 major and 2 minor or 3 minor criteria</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>*Low-risk populations are those with ARF incidence ≤2 per 100 000 school-aged children or all-age rheumatic heart disease prevalence of ≤1 per 1000 population per year. If the incidence exceeds the given limit, then it is moderate-high risk populations.<br><br>Pearl PM0598: American Heart Association (AHA) recommendation for duration of secondary prophylaxis of rheumatic fever<br><br><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Category</strong></p>\n</td>\n<td>\n<p><strong>Duration after the last attack</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rheumatic fever without carditis</p>\n</td>\n<td> \n<p>5 years or until 21 years of age (whichever is longer)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rheumatic fever with carditis but no residual heart disease (no valvular disease)</p>\n</td>\n<td> 10 years or until 21 years of age (whichever is longer)</td>\n</tr>\n<tr>\n<td>\n<p>Rheumatic fever with carditis and residual heart disease (persistent valvular disease)</p>\n</td>\n<td>\n<p>10 years or until 40 years of age (whichever is longer), sometimes lifelong prophylaxis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "9. A patient has been on warfarin therapy for the past 6 months after suffering from deep vein thrombosis. Administration of which of the following drugs would increase the risk of hemorrhage in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Ketoconazole"
        },
        {
          "id": 2,
          "text": "Griseofulvin"
        },
        {
          "id": 3,
          "text": "Carbamazepine"
        },
        {
          "id": 4,
          "text": "Phenobarbitone"
        }
      ],
      "correct_choice_id": 1,
      "solution": "The administration of ketoconazole would increase the risk of hemorrhage in a patient who is on warfarin. <br><br>Warfarin is metabolized by a CYP2C9 cytochrome complex and ketoconazole is an enzyme inhibitor. Co-administration of these two drugs will result in decreased metabolism of warfarin leading to increased plasma concentration. This results in warfarin overdose and subsequent haemorrhagic symptoms. <br><br>Other drugs that can enhance the risk of hemorrhage on co-administration with warfarin include amiodarone, cimetidine, metronidazole, clopidogrel, isoniazid, cotrimoxazole, etc. <br><br><table>\n<tbody>\n<tr>\n<td><strong><span class=\"tlJRLogE\">Enz</span><span class=\"ionqPzzz\">ym</span><span class=\"JxKKwoet\">e</span> <span class=\"gQYbMFxH\">in</span><span class=\"mSpUZwKI\">du</span><span class=\"iJDQxQaq\">cers</span></strong></td>\n<td><strong><span class=\"VSLvHVIF\">Enz</span><span class=\"aOIkyGgY\">yme</span> <span class=\"XvvgiWAK\">inhi</span><span class=\"jLnLOPPp\">bito</span><span class=\"OoYDAhMp\">rs</span></strong></td>\n</tr>\n<tr>\n<td>\n<p><span class=\"mfrCsoTZ\">Mnem</span><span class=\"rWDeNhRk\">on</span><span class=\"GTBRrrZo\">ic:</span> <span class=\"IXOilkVl\">CRAP</span> <span class=\"niYTsbdK\">GPS</span></p>\n<ul>\n<li><strong><span class=\"TIaBKxSi\">C</span></strong><span class=\"xoLwebyj\">arba</span><span class=\"HjDpfrcp\">maze</span><span class=\"tlJRLogE\">pi</span><span class=\"QOgmFJOA\">ne</span></li>\n<li><strong><span class=\"gUMQiCMX\">R</span></strong><span class=\"PrrPffow\">if</span><span class=\"fmjOGlZX\">amp</span><span class=\"wCqJOUuo\">icin</span></li>\n<li><strong><span class=\"TzKRatWN\">A</span></strong><span class=\"JTuwKOXs\">lc</span><span class=\"GTBRrrZo\">oho</span><span class=\"JxKKwoet\">l</span> <span class=\"GCPVWzMD\">(c</span><span class=\"XvvgiWAK\">hr</span><span class=\"niYTsbdK\">onic</span><span class=\"KBhStQbx\">)</span></li>\n<li><strong><span class=\"kSBcDzoa\">P</span></strong><span class=\"zFtJaDpt\">he</span><span class=\"QMvMULrV\">ny</span><span class=\"gVuGIDfY\">to</span><span class=\"MokvZVRv\">in</span></li>\n<li><strong><span class=\"vLvMKjYv\">G</span></strong><span class=\"fmjOGlZX\">rise</span><span class=\"cLoJQvwe\">of</span><span class=\"GQKLRDwa\">ulv</span><span class=\"niYTsbdK\">in</span></li>\n<li><strong><span class=\"gQYbMFxH\">P</span></strong><span class=\"VSLvHVIF\">heno</span><span class=\"gQYbMFxH\">barb</span><span class=\"cLoJQvwe\">iton</span><span class=\"PrrPffow\">e</span></li>\n<li><strong><span class=\"HGhvMLYn\">S</span></strong><span class=\"KQMikzwQ\">ulf</span><span class=\"qHTWoJbg\">onyl</span><span class=\"aOIkyGgY\">ure</span><span class=\"rWDeNhRk\">as</span></li>\n</ul>\n</td>\n<td>\n<p><span class=\"rnrXbSca\">Mn</span><span class=\"jLnLOPPp\">emon</span><span class=\"TkCMTRjU\">ic</span><span class=\"HjDpfrcp\">:</span> <span class=\"imKssJMp\">RED</span> <span class=\"KUlHcIWU\">VICK</span></p>\n<ul>\n<li><strong><span class=\"eTXYvqcB\">R</span></strong><span class=\"SDAwPsVZ\">iton</span><span class=\"sVdtYcpp\">avir</span></li>\n<li><strong><span class=\"cqDpoLvR\">E</span></strong><span class=\"xoLwebyj\">ryth</span><span class=\"zFtJaDpt\">romy</span><span class=\"NUHoYETG\">cin</span></li>\n<li><strong><span class=\"SzFiAwIc\">D</span></strong><span class=\"cYVUiOEY\">ilti</span><span class=\"EqVkQGBE\">aze</span><span class=\"qHTWoJbg\">m</span></li>\n<li><strong><span class=\"BkUxKAOI\">V</span></strong><span class=\"XvbFNFid\">era</span><span class=\"qHTWoJbg\">pa</span><span class=\"VbeOBQVK\">mi</span><span class=\"MugkeLwm\">l,</span> <span class=\"KQMikzwQ\">Valp</span><span class=\"JvvYODff\">ro</span><span class=\"VkwFfeGs\">at</span><span class=\"gqGlpVxN\">e</span></li>\n<li><strong><span class=\"TzKRatWN\">I</span></strong><span class=\"uryMdNZD\">trac</span><span class=\"wCqJOUuo\">onaz</span><span class=\"Azgkpisw\">ole</span></li>\n<li><strong><span class=\"KQMikzwQ\">C</span></strong><span class=\"iJDQxQaq\">lari</span><span class=\"WqxvtGoJ\">thro</span><span class=\"BgbNDiZf\">myci</span><span class=\"imKssJMp\">n,</span> <span class=\"YJxwUpnM\">Ci</span><span class=\"pybSdtgH\">meti</span><span class=\"FYEmJqWA\">dine</span></li>\n<li><strong><span class=\"oOWEidtp\">K</span></strong><span class=\"UhshGKMM\">et</span><span class=\"JvvYODff\">oc</span><span class=\"MNmqSFWs\">ona</span><span class=\"IrsMnQcy\">zole</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>Other options:<br><br>Griseofulvin, carbamazepine, and phenobarbitone are enzyme inducers. These will cause excess degradation of warfarin leading to ineffective anti-coagulant treatment.",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "10. A patient on heparin develops heparin-induced thrombocytopenia. Heparin is stopped immediately. Which of the following drugs should be avoided as an alternate anticoagulant?",
      "choices": [
        {
          "id": 1,
          "text": "Bivalirudin"
        },
        {
          "id": 2,
          "text": "Argatroban"
        },
        {
          "id": 3,
          "text": "Fondaparinux"
        },
        {
          "id": 4,
          "text": "Enoxaparin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "Enoxaparin, a low-molecular-weight heparin (LMWH), should not be given as an alternate anticoagulant in cases of heparin-induced thrombocytopenia (HIT) because they cross-reacts with heparin antibodies.<br><br>Heparin-induced thrombocytopenia occurs in about 0.5% of medical patients 5–10 days after initiation of heparin therapy. It refers to platelet count < 150,000/mL or a 50% decrease from the pretreatment value.<br><br>IgG antibodies are formed against complexes of heparin with platelet factor 4 are formed causing most of the symptoms. Venous thromboembolism occurs most commonly. Arterial thrombosis can also occur, causing limb ischemia, myocardial infarction, or stroke.<br><br>Management: If unexplained thrombocytopenia or any of the clinical manifestations mentioned occur 5 or more days after the beginning of the therapy, regardless of the dose or route of administration, heparin or LMWH should be discontinued immediately. The diagnosis of HIT can be confirmed with a heparin-dependent platelet activation assay or an immunoassay for antibodies that react with heparin–platelet factor 4 complexes.<br><br>An alternative anticoagulant, such as bivalirudin (Option A), argatroban (Option B), or fondaparinux (Option C)should be administered to patients with heparin-induced thrombocytopenia, as thrombotic complications may occur after cessation of therapy. LMWHs such as enoxaparin and dalteparin should be avoided. (Option D)",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "11. A 50-year-old man presented to the emergency room with difficulty breathing and chest pain. On examination, tachycardia, edema of the lower limbs, and elevated jugular venous pressure were noted. He was given an intravenous infusion of a natriuretic peptide that acts on membrane-bound guanylyl cyclase. Identify the drug administered.",
      "choices": [
        {
          "id": 1,
          "text": "Furosemide"
        },
        {
          "id": 2,
          "text": "Sodium nitroprusside"
        },
        {
          "id": 3,
          "text": "Nitroglycerin"
        },
        {
          "id": 4,
          "text": "Nesiritide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "The given clinical scenario is suggestive of heart failure and the drug administered is nesiritide.  <br><br>Nesiritide is a recombinant natriuretic peptide acting on membrane-bound guanylyl cyclase. It is used in the management of heart failure. <br><br>Natriuretic peptides: <br><br>* Atrial natriuretic peptide (ANP): released from atrial storage granules in response to increase in intravascular volume. It reduces blood pressure.  <br><br>* Brain natriuretic peptide (BNP): released from ventricular tissue in response to volume overload. It reduces blood pressure and is also known to reduce cardiac hypertrophy and fibrosis.  <br><br>* C- type natriuretic peptide (CNP): synthesized in the brain and endothelial tissues and stimulates the growth of long bones. <br><br>The other drugs mentioned are also used in the management of heart failure. Furosemide is a loop diuretic that acts on the thick ascending loop of Henle, inhibiting the Na+K+Cl- channel. Sodium nitroprusside and nitroglycerine are vasodilators that act by releasing nitric oxide (NO). NO acts on soluble guanylyl cyclase leading to vasodilation.<br><br>Pearl PM0371: Mechanisms of Action of Hormones<br><br><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Types of hormone receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to intracellular receptors</strong></td>\n</tr>\n<tr>\n<td><strong>Cytoplasmic receptors</strong></td>\n<td>\n<p>Glucocorticoids</p>\n<p>Minerolocorticoids</p>\n<p>Androgens</p>\n<p>Vitamin D</p>\n</td>\n</tr>\n<tr>\n<td><strong>Nuclear receptors</strong></td>\n<td>\n<p>Thyroid hormones</p>\n<p>Vitamin A</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to cell surface receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\">1) <strong>G-protein coupled receptors</strong> (GPCR)</td>\n</tr>\n<tr>\n<td><strong>Gs</strong>: stimulation of second messenger cAMP</td>\n<td>\n<p>ACTH, CRH</p>\n<p>TSH, GHRH</p>\n<p>FSH, LH, hCG</p>\n<p>Vasopressin (V2 receptors)</p>\n<p>Catecholamines (β receptors)</p>\n<p>Somatostatin</p>\n<p>Glucagon</p>\n<p>Secretin</p>\n<p>Parathyroid hormone</p>\n</td>\n</tr>\n<tr>\n<td><strong>Gi</strong>: inhibition of second messenger cAMP</td>\n<td>\n<p>Catecholamines (⍺<sub>2 </sub>receptors)</p>\n<p>Acetylcholine (M2, M4)</p>\n<p>Somatostatin</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\"><strong>Gq: </strong>second messenger is <strong>phospholipase C </strong>or <strong>cGMP</strong><br/><br/></td>\n<td>\n<p>second messenger is <strong>phospholipase C :</strong></p>\n<p>Catecholamines (⍺1 receptors)</p>\n<p>GnRH, GHRH, TRH</p>\n<p>Vasopressin (V1 receptor)</p>\n<p>Gastrin</p>\n<p>Cholecystokinin</p>\n<p>Oxytocin</p>\n<p>Acetylcholine (M1, M3, M5)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>second messenger is <strong>cGMP:</strong></p>\n<p>Nitric Oxide</p>\n<p>Atrial natriuretic peptide</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">2) Receptors using <strong>t</strong><strong>yrosine kinase</strong></td>\n</tr>\n<tr>\n<td><strong>JAK-STAT </strong>(non-receptor tyrosine kinase) </td>\n<td>\n<p>Erythropoietin</p>\n<p>Growth hormone</p>\n<p>Prolactin</p>\n</td>\n</tr>\n<tr>\n<td><strong>MAP kinase </strong>(receptor tyrosine kinase) pathway </td>\n<td>\n<p>Growth factors like IGF, VEGF, FGF, PDGF</p>\n<p>Insulin</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>Notes: \n1. Although cytoplasmic receptors are present in the cytoplasm, once the hormone-receptor complex is formed, it moves to the nucleus to initiate its actions.<br><br>2. Vitamin D is a cytoplasmic receptor. All intracellular receptors are inherently nuclear receptors, as they bind and become activated in the nucleus, as mentioned above. However, they have two primary sites of action: the cytoplasm and the nucleus. <br><br>3. While receptor tyrosine kinases have intrinsic tyrosine kinase activity, non-receptor tyrosine kinases have an external tyrosine kinase component that interacts with the receptor as and when required.<br><br>Pearl PM2320: Drugs used in heart failure<br><br>Drugs used in acute decompensated heart failure:<br><br> <br><br><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Intravenous vasodilators</strong></td>\n</tr>\n<tr>\n<td>\n<p>Nitroglycerine</p>\n<p>Sodium nitroprusside</p>\n</td>\n<td>Decrease preload and afterload</td>\n</tr>\n<tr>\n<td>Nesiritide</td>\n<td>Recombinant human BNP</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br> <br><br><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Intravenous positive inotropes</strong></td>\n</tr>\n<tr>\n<td>\n<p>Dobutamine</p>\n<p>Dopamine</p>\n<p>Epinephrine</p>\n<p>Norepinephrine</p>\n</td>\n<td>β1 receptor-mediated stimulation of cardiac output</td>\n</tr>\n<tr>\n<td>\n<p>Enoximone</p>\n<p>Milrinone</p>\n</td>\n<td>PDE 3/4 inhibitors</td>\n</tr>\n<tr>\n<td>\n<p>Levosimendan</p>\n<p>Pimobendan</p>\n</td>\n<td>Combined Ca<sup>2+</sup> sensitizers and PDE3 inhibitors</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br> <br><br><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Drugs used for rapid symptom relief</strong></td>\n</tr>\n<tr>\n<td>\n<p>Bumetanide</p>\n<p>Furosemide</p>\n<p>Torasemide</p>\n</td>\n<td>Loop diuretics- used for symptomatic treatment of severe heart failure and acute decompensation.</td>\n</tr>\n<tr>\n<td>Morphine</td>\n<td>Opioid - to calm the patient and decreases cardiac O2 consumption</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br> <br><br>Drugs used in chronic heart failure:<br><br><table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td>ACE inhibitors</td>\n<td>Used as first-line therapy</td>\n</tr>\n<tr>\n<td>ARBs</td>\n<td>Used in case of intolerance to ACE inhibitors</td>\n</tr>\n<tr>\n<td>Beta-blockers</td>\n<td>Used as first-line therapy  </td>\n</tr>\n<tr>\n<td>\n<p>Spironolactone</p>\n<p>Eplerenone</p>\n</td>\n<td>Mineralocorticoid receptor antagonists - first-line drugs for symptomatic heart failure.</td>\n</tr>\n<tr>\n<td>SGLT-2 inhibitors</td>\n<td>Used as 1st line therapy- reduces mortality and morbidity</td>\n</tr>\n<tr>\n<td>Sacubitril/Valsartan</td>\n<td>Neprilysin inhibitor/ARB(ARNI)</td>\n</tr>\n<tr>\n<td>Ivabradine</td>\n<td>Inhibitor of I<sub>f</sub> current in the sinoatrial node</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "12. A patient was diagnosed with pulmonary tuberculosis and was started on first-line antitubercular drugs. Which of the following is the adverse effect of the drug that is activated by catalase-peroxidase enzyme inside the mycobacteria?",
      "choices": [
        {
          "id": 1,
          "text": "Peripheral neuritis"
        },
        {
          "id": 2,
          "text": "Optic neuritis"
        },
        {
          "id": 3,
          "text": "Hyperuricemia"
        },
        {
          "id": 4,
          "text": "Flu-like illness"
        }
      ],
      "correct_choice_id": 1,
      "solution": "Isoniazid is a first-line bactericidal drug that is used for the treatment of tuberculosis. This drug enters bacilli by passive diffusion. It then gets activated to its toxic form by the enzyme catalase-peroxidase encoded by the kat gene. It acts by inhibiting the synthesis of mycolic acid. Peripheral neuritis is the side effect of isoniazid.<br><br>Side effects of isoniazid:<br><br>* Peripheral neuritis - It occurs due to interference with the production of active coenzyme pyridoxal phosphate from pyridoxine. Therefore, pyridoxine 10 mg/day (vitamin B6) is given prophylactically along with isoniazid to prevent neurotoxicity.<br><br>* Hepatitis - Isoniazid must be stopped at the first sign of hepatotoxicity.<br><br>* Rashes<br><br>* Anemia<br><br>* Arthralgia<br><br>Toxicity of isoniazid results in metabolic acidosis, seizures, and coma.<br><br>Other options:<br><br>Option B: Optic neuritis is an important side effect of ethambutol. It results in decreased visual acuity and loss of red-green discrimination. Ethambutol inhibits arabinose transferase III, thereby decreasing arabinogalactan biosynthesis. This results in disruption in mycobacterial cell wall synthesis.<br><br>Option C: Pyrazinamide causes hyperuricemia and hepatotoxicity. Pyrazinamide is a prodrug, it is converted into an active metabolite pyrazinoic acid, which makes the intracellular environment acidic, thereby killing the bacteria.<br><br>Option D: Flu-like illness is associated with rifampin. It binds to DNA-dependent RNA polymerase to form a stable drug-enzyme complex. This complex suppresses RNA synthesis. Other side effects of rifampin are hepatitis and orange-red discoloration of urine and body secretions.<br><br>Pearl PM1270: General properties of the first line drugs in TB<br><br><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>First-line drugs</strong></span></div>\n</td>\n<td>\n<div><span><strong>Isoniazid</strong></span></div>\n</td>\n<td>\n<div><span><strong>Rifampicin</strong></span></div>\n</td>\n<td>\n<div><span><strong>Pyrazinamide</strong></span></div>\n</td>\n<td>\n<div><span><strong>Ethambutol</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Mechanism</strong></span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n<div><span>(Maximum)</span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n</td>\n<td>\n<div><span>Bacteriostatic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Location of Mycobacteria</strong></span></div>\n</td>\n<td>\n<div><span>Intracellular +  Extracellular</span></div>\n</td>\n<td>\n<div><span>Intracellular +  Extracellular</span></div>\n</td>\n<td>\n<div><span>Intracellular</span></div>\n</td>\n<td>\n<div><span>Extracellular</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Metabolism</strong></span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n<div><span>(Maximum)</span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n</td>\n<td>\n<div><span>Kidney</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>Pearl PM1720: ATT Regimen for TB Patients<br><br>As per the latest recommendations from National Tuberculosis Elimination Programme (NTEP), treatment of TB is now based primarily on drug susceptibility testing. This is irrespective of new cases, previously treated cases or recurrent TB cases. \nAll cases of TB are treated with Drug Sensitive TB Regimen, as long as the patient is sensitive to isoniazid and rifampicin. (No classification into category I or II)<br><br><table>\n<tbody>\n<tr>\n<td><strong>Type of TB Case</strong></td>\n<td><strong>Intensive Phase</strong></td>\n<td><strong>Continuation Phase</strong></td>\n</tr>\n<tr>\n<td>New and previously treated cases (H and R sensitive)</td>\n<td>2 months HRZE</td>\n<td>4 months HRE (Only HR as per WHO guidelines)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>Classification based on drug resistance. <br><br>The cases are classified as:<br><br>* Mono-resistant (MR): A TB patient who is resistant to one 1st line anti-TB drug only.<br><br>* Poly-Drug Resistant (PDR): A TB patient, who is resistant to more than one 1st line anti-TB drug, other than Rifampicin and isoniazid. <br><br>* Rifampicin Resistant (RR): A TB patient who is resistant to rifampicin with or without resistance to other drugs. Patients, who have rifampicin resistance, should be managed as if they are an MDR TB case.<br><br>* Multi-Drug Resistant (MDR): A TB patient who is resistant to both isoniazid and rifampicin.<br><br>* Extensively Drug-Resistant (XDR): A MDR TB patient who is additionally resistant to a fluoroquinolone (ofloxacin, levofloxacin, or moxifloxacin) and at least one additional group A drug (as of 2021, these are bedaquiline and linezolid)<br><br>Standard DR TB regimen<br><br><table>\n<tbody>\n<tr>\n<td><strong>Regimen class</strong></td>\n<td><strong>Drugs</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/ poly-drug resistant TB regimen</strong></td>\n<td>Lfx R E Z for 6 months</td>\n<td>\n<p>6 months long</p>\n<p>Oral drugs only</p>\n</td>\n</tr>\n<tr>\n<td><strong>BPaLM regime (New MDR regime by WHO)</strong></td>\n<td>Bdq Pa Lzd Mfx for 6 months</td>\n<td>\n<p>6 months long</p>\n</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter oral bedaquiline regime (Shorter MDR)</strong></td>\n<td>\n<p><strong>Intensive Phase:</strong></p>\n<p>Lfx Bdq(6 months) Cfz Z Hh E Eto for 4-6 months</p>\n<p><strong>Continuation phase:</strong></p>\n<p>Lfx Cfz Z E for 5 months</p>\n</td>\n<td>\n<p>9-11 months long totally</p>\n<p>Injectables used in Intensive phase.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Bdq(6 months or longer) Lfx Lzd Cfz Cs </td>\n<td>\n<p>18-20 months long</p>\n<p>Oral drugs only</p>\n<p>This regimen is used for XDR TB patients for 20 months.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br> \nCriteria for patients to receive standard Drug Resistant TB regimen:<br><br><table>\n<tbody>\n<tr>\n<td><strong>Standard Drug Resistant TB regimen</strong></td>\n<td><strong>Inclusion criteria</strong></td>\n<td><strong>Exclusion criteria</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/poly-drug resistant TB regimen</strong></td>\n<td><strong>Isoniazid resistant</strong> TB with <strong>rifampicin sensitive</strong></td>\n<td>No specific criteria</td>\n</tr>\n<tr>\n<td><strong>BPaLM regimen (New MDR TB regimen by WHO)</strong></td>\n<td>\n<ol>\n<li><strong>MDR/RR-TB</strong> </li>\n<li>Those with <strong>confirmed</strong> pulmonary TB and all forms of extrapulmonary TB (except for TB involving CNS, osteoarticular, and miliary TB).</li>\n<li>Patients <strong>&gt;14 years of age.<br/></strong></li>\n</ol>\n</td>\n<td>\n<p>Pregnant and lactating women</p>\n<p>Patients with uncontrolled cardiac arrhythmia that requires medication</p>\n</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter MDR TB regimen</strong></td>\n<td>Patient with <strong>rifampicin resistant</strong> pulmonary or extra pulmonary TB</td>\n<td>Non drug sensitivity test based criteria:\n<ul>\n<li>Pregnancy</li>\n<li>Any extra pulmonary disease in PLHIV</li>\n<li>Disseminated meningeal or central nervous system TB</li>\n<li>Intolerance to any drug in the shorter MDR TB regimen</li>\n</ul>\nDrug sensitivity test based criteria:\n<ul>\n<li>If DST/DRT result for FQ or SLI is resistant (XDR TB)</li>\n<li>Presence of InhA mutation</li>\n<li>Resistant to Z </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Patients in whom <strong>shorter MDR TB regimen cannot be considered</strong> due to any reason</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>Legend<br><br>FQ: Fluoroquinolone<br><br>SLI: Second Line Injectable<br><br>PLHIV: People Living with HIV<br><br>Lfx: Levofloxacin<br><br>Pa: Pretomanid<br><br>H: Isoniazid<br><br>Hh: High Dose Isoniazid<br><br>R: Rifampicin<br><br>E: Ethambutol<br><br>Z: Pyrazinamide<br><br>Mfx: Moxifloxacin<br><br>Km: Kanamycin<br><br>Am: Amikacin<br><br>Eto: Ethionamide<br><br>Cfz: Clofazimine<br><br>Bdq: Bedaquiline<br><br>Lzd: Linezolid<br><br>Cs: Cycloserine",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "13. A 40-year-old man comes to the clinic with a constant ringing sensation in his left ear. He has had these symptoms for the past 3 months with a progressive decrease in hearing in the same ear. He also complains that he has dizziness occasionally. On oral administration of glycerol, the patient reports improvement in hearing in his left ear. He has been prescribed a drug that is supposed to dilate blood vessels in his ears. What is the mechanism of action of this drug?<br><br>H: refers to Histamine",
      "choices": [
        {
          "id": 1,
          "text": "H1 agonist"
        },
        {
          "id": 2,
          "text": "H1 antagonist"
        },
        {
          "id": 3,
          "text": "H2 agonist"
        },
        {
          "id": 4,
          "text": "H2 antagonist"
        }
      ],
      "correct_choice_id": 1,
      "solution": "The presenting symptoms along with improvement in hearing with Glycerol test narrows down to diagnosis of Meniere's disease and Betahistine is used to treat vertigo in Meniere's disease.<br><br>Betahistine is a selective H1 agonist. It causes vasodilation in the inner ear which improves circulation. <br><br>Meniere's disease (MD) or endolymphatic hydrops is a disorder of the inner ear caused by impaired endolymph resorption. It is characterized by an episodic sudden onset of vertigo, low-frequency hearing loss (in the early stages of the disorder), low-frequency roaring tinnitus, and sensation of fullness in the affected ear<br><br>Glycerol test is done in Meniere's disease.<br><br>* Glycerol is a dehydrating agent.<br><br>* When given orally, it reduces endolymph pressure and thus causes an improvement in hearing.<br><br>* The test has a diagnostic and prognostic value.<br><br>* These days, glycerol test is combined with electrocochleography.<br><br>Betahistine (Vertin), used in the medical management of Meniere's disease acts by causing dilatation of the labyrinthine blood vessels, thereby improving the microvascular circulation in the stria vascularis of the cochlea. It is also found to inhibit vestibular nuclei activity.<br><br>Side-effects:<br><br>It is contraindicated in asthmatics and ulcer patients<br><br>Other drugs used in the medical management of Meniere's disease are<br><br>* Prochlorperazine (stemetil), is a vestibular sedative.<br><br>* Diazepam (Valium or Calmpose) 5–10 mg may be given intravenously. It has a tranquillizing effect and also suppresses the activity of the medial vestibular nucleus.<br><br>* In some patients, an acute attack can be stopped by atropine, 0.4 mg, given subcutaneously<br><br>* Diuretics such as furosemide and hydrochlorothiazide are used to control recurrent attacks.<br><br>* Propantheline bromide (probanthine), an anticholinergic agent is also found to be effective.",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "14. A 40-year-old factory worker presented with the following lesion on the face. She gives a history of itchy, scaly lesions with central clearing and raised margins. She applied some topical ointment after which the itching subsided and she felt relief. However, these lesions appeared once she stopped applying that ointment. A microscopic examination revealed the presence of fungal mycelium. What is the likely ointment she had applied earlier?",
      "choices": [
        {
          "id": 1,
          "text": "Terbinafine"
        },
        {
          "id": 2,
          "text": "Beclomethasone"
        },
        {
          "id": 3,
          "text": "Miconazole"
        },
        {
          "id": 4,
          "text": "Neomycin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "The given clinical scenario with an image of an atypical clinical lesion of tinea, usually produced by incorrect treatment of fungal infection with a topical corticosteroid(beclomethasone here). It points towards a diagnosis of Tinea incognito. <br><br>* Steroids suppress inflammation without eliminating the fungus; so the typical raised margin is diminished, scaling is lost and inflammation reduces. Hence, diagnosis becomes difficult. Once steroid dosage is decreased or stopped, scaling reappears and shows fungal mycelium.<br><br>* Treatment: Oral terbinafine or itraconazole<br><br>Tinea corporis/ ringworm infection is caused by the dermatophyte Trichophyton rubrum. It results from the invasion and proliferation of the causal fungi in the stratum corneum with lesions on the trunk and limbs. <br><br>Characteristic lesions are circular, usually sharply marginated with a raised edge with central resolution. Scaling is a common but not a constant finding. The diagnosis is mostly clinical. In case of doubt, skin scrapings from site of lesion examined under a microscope may show fungal mycelium.<br><br>Pharmacological treatment of fungal Tinea infection is :<br><br>Localized disease, recent onset<br><br>* Topical terbinafine twice daily for 2 weeks<br><br>* Topical azole once or twice daily for 2–4 weeks<br><br>Widespread disease<br><br>* First-line:\nOral terbinafine 250 mg/day 2–3 weeks\nOral Itraconazole 100 mg/day 2–4 weeks<br><br>* Second line:\nOral Griseofulvin 1 g/day for 4 weeks",
      "explanation_video": "",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/bee81622a91847d292ff70b673f9758a.png"
      ],
      "explanation_images": []
    },
    {
      "text": "15. A patient is treated with an alkylating agent A, for the treatment of steroid-dependent nephrotic syndrome. This drug A is also used as part of the regime for treating NHL. The patient now starts passing blood in the urine. Another drug B is used for treating the ‘bloody urine’. All of the following statements are correct regarding the drugs A&B except?<br><br>NHL: Non Hodgkin Lymphoma",
      "choices": [
        {
          "id": 1,
          "text": "Blood in urine is due to acrolein produced by metabolism of drug A"
        },
        {
          "id": 2,
          "text": "Both drugs A & B can be administered oral or IV"
        },
        {
          "id": 3,
          "text": "Hemorrhagic myocardial necrosis can be caused by high dose therapy with drug A"
        },
        {
          "id": 4,
          "text": "Fluid restriction is advised during high dose treatment with drug A to reduce side effects"
        }
      ],
      "correct_choice_id": 4,
      "solution": "Drug A is cyclophosphamide, and Drug B is MESNA. Vigorous intravenous hydration, not fluid restriction, is advised during high-dose treatment with cyclophosphamide to reduce hemorrhagic cystitis.<br><br>Cyclophosphamide is used for the treatment of steroid-dependent nephrotic syndrome and is also used as part of the regimen for treating NHL. Both cyclophosphamide and MESNA can be administered orally as well as intravenously(Option B).<br><br>MESNA is used to treat hemorrhagic cystitis caused by the cyclophosphamide metabolite acrolein(Option A). Cystitis caused by cyclophosphamide is treated by systemic administration of mesna and by irrigating the bladder with acetylcysteine, which detoxifies the toxic metabolites. Plenty of fluids and frequent bladder voiding are also helpful.<br><br>Hemorrhagic myocardial necrosis (Option C) may occur after high-dose therapy with total doses greater than 200 mg/kg.<br><br>Pearl PM2286: Types of Cystitis<br><br><table>\n<tbody>\n<tr>\n<td><strong>Type of cystitis</strong></td>\n<td><strong>Etiology</strong></td>\n<td><strong>Characteristic features</strong></td>\n</tr>\n<tr>\n<td>Interstitial cystitis</td>\n<td>Idiopathic</td>\n<td>Hunner's ulcer</td>\n</tr>\n<tr>\n<td>Polypoid cystitis</td>\n<td>Catheterization of bladder</td>\n<td>Mimics malignancy</td>\n</tr>\n<tr>\n<td>Malakoplakia</td>\n<td>Defective phagocytosis</td>\n<td>Michaelis– Gutmann bodies</td>\n</tr>\n<tr>\n<td>Eosinophilic cystitis</td>\n<td>Systemic allergic disorders</td>\n<td>Submucosal eosinophils</td>\n</tr>\n<tr>\n<td>Emphysematous cystitis</td>\n<td><em>Clostridium perfringens</em></td>\n<td>Associated with Diabetes</td>\n</tr>\n<tr>\n<td>Follicular cystitis</td>\n<td>Prolonged urinary retention, intravesicular chemotherapy or BCG</td>\n<td>Lymphoid follicles within bladder mucosa</td>\n</tr>\n<tr>\n<td>Hemorrhagic cystitis</td>\n<td>\n<p>Cyclo-phosphamide, BK virus, Adenovirus</p>\n</td>\n<td>Prophylactic administration of mesna reduces the incidence</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "16. A 26-year-old woman presents with a unilateral throbbing headache associated with nausea and vomiting. She has had similar episodes in the past where the headache usually lasts for 1-2 days. Bright light increases her discomfort and she prefers sitting in a dark room. Which of the following are used to prevent further episodes of this condition?<br><br>* Sumatriptan<br><br>* Propranolol<br><br>* Naproxen<br><br>* Topiramate<br><br>* Transcranial magnetic stimulation",
      "choices": [
        {
          "id": 1,
          "text": "2 and 4 only"
        },
        {
          "id": 2,
          "text": "1, 2 and 3"
        },
        {
          "id": 3,
          "text": "2, 4 and 5"
        },
        {
          "id": 4,
          "text": "1, 2, 3 and 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "The given clinical scenario featuring unilateral throbbing headache with aura (photophobia, nausea, vomiting) is suggestive of migraine with aura. Options 2,4, and 5, i.e. propranolol, topiramate, and transcranial magnetic stimulation, are used for prophylaxis against migraine.<br><br>Sumatriptan and naproxen are used in the acute management of migraine (not used as preventive medication).<br><br>Other drugs used in the prophylaxis of migraine:<br><br>* Beta-blockers - propranolol, metoprolol<br><br>* Antidepressants - amitriptyline, venlafaxine<br><br>* Anticonvulsants - valproate, topiramate<br><br>* Serotonergic drugs - pizotifen<br><br>* Flunarizine, Candesartan<br><br>* CGRP antagonists - erenumab, fremanezumab, galcanezumab, eptinezumab.<br><br>Other modalities of preventive treatment:<br><br>* Onabotulinum toxin A <br><br>* Neuromodulation: A single-pulse transcranial magnetic stimulation (sTMS) is delivered with a hand-held device (FDA approved) that creates a fluctuating magnetic field that triggers an electric current that modifies cortical excitability.<br><br>Drugs with no role in prophylaxis :<br><br>* Calcium channel blockers - verapamil, nimodipine<br><br>* α2 adrenergic agonist - clonidine<br><br>* Selective serotonin reuptake inhibitors - fluoxetine<br><br>Pearl PM1996: Simplified diagnostic criteria for migraine<br><br>Repeated attacks of headache lasting 4-72 h in patients with a normal physical examination with no other reasonable cause for the headache, and<br><br>At least 2 of the following features:<br><br>* Unilateral pain<br><br>* Throbbing pain<br><br>* Aggravation by movement<br><br>* Moderate or severe intensity<br><br>Plus at least 1 of the following features:<br><br>* Nausea/vomiting<br><br>* Photophobia and phonophobia",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "17. A patient was brought to the hospital after he collapsed on the dance floor. The findings of a 12-lead ECG taken at the emergency room are shown in the image below. Which of the following drugs could have precipitated the associated condition?",
      "choices": [
        {
          "id": 1,
          "text": "Domperidone"
        },
        {
          "id": 2,
          "text": "Metoclopramide"
        },
        {
          "id": 3,
          "text": "Cisapride"
        },
        {
          "id": 4,
          "text": "Omeprazole"
        }
      ],
      "correct_choice_id": 3,
      "solution": "The above clinical scenario along with the ECG findings are suggestive of torsades de pointes. Among the given options, cisapride is most likely to have precipitated this condition.<br><br>Cisapride is a prokinetic agent. Its prokinetic action is exerted mainly through 5-HT4 agonism aided by weak 5-HT3 antagonism.<br><br>At high concentrations, cisapride blocks delayed rectifying K+ channels in the heart which prolongs Q-Tc interval and predisposes to torsades de pointes/ ventricular fibrillation.<br><br>The illustration given below shows the ECG findings of torsades de pointes.<br><br><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2335fea15a244424bcc9cc24c52cb666x1280x1424.JPEG\" alt=\"Explanation Image\"><br><br>Other options:<br><br>Option A: Domperidone can cause galactorrhea, gynecomastia, amenorrhea, or impotence.<br><br>Option B: Metoclopramide can cause dystonias, parkinsonian-like symptoms, and tardive dyskinesia. Extrapyramidal effects occur more commonly in children.<br><br>Option D: Adverse effects of omeprazole include headache, nausea, diarrhea, and accelerated osteoporosis in the elderly.<br><br>Pearl PM1203: Etiology of Torsade De Pointes<br><br>Acquired prolongation of QT interval<br><br>Electrolyte abnormalities<br><br>* Hypokalemia<br><br>* Hypomagnesemia<br><br>* Hypocalcemia<br><br>Drugs<br><br>* Antiarrhythmic drugs<br><br>* Class IA: Quinidine, disopyramide, procainamide<br><br>* Class III: Sotalol, amiodarone (QT prolongation common but torsade ventricular tachycardia is rare), ibutilide, dofetilide, almokalant<br><br>* Antibiotics<br><br>* Macrolides: Erythromycin, clarithromycin, azithromycin<br><br>* Fluoroquinolones: Levofloxacin, moxifloxacin, gatifloxacin<br><br>* Trimethoprim-sulfamethoxazole<br><br>* Clindamycin<br><br>* Pentamidine<br><br>* Chloroquine<br><br>* Antifungals: Ketoconazole, itraconazole<br><br>* Antivirals<br><br>* Antipsychotics<br><br>* Antihistamines<br><br>Pearl PM2414: Drugs causing QT prolongation and torsades de pointes<br><br>Drugs Associated with QT Prolongation and Torsades de Pointes:<br><br>Antiarrhythmics:<br><br>* Sotalol<br><br>* Amiodarone<br><br>* Quinidine<br><br>* Procainamide<br><br>* Dofetilide<br><br>* Ibutilide<br><br>Antimicrobials:<br><br>* Levofloxacin<br><br>* Ciprofloxacin<br><br>* Gatifloxacin<br><br>* Moxifloxacin<br><br>* Clarithromycin<br><br>* Erythromycin<br><br>* Ketoconazole<br><br>* Itraconazole<br><br>* Rilpivirine<br><br>Antidepressants:<br><br>* Amitriptyline<br><br>* Desipramine<br><br>* Imipramine<br><br>* Doxepin<br><br>* Fluoxetine<br><br>* Sertraline<br><br>* Venlafaxine<br><br>Antipsychotics:<br><br>* Haloperidol<br><br>* Droperidol<br><br>* Quetiapine<br><br>* Ziprasidone<br><br>* Thioridazine<br><br>Others:<br><br>* Cisapride<br><br>* Sumatriptan<br><br>* Zolmitriptan<br><br>* Arsenic<br><br>* Dolasetron<br><br>* Methadone<br><br>Pearl PM2440: ECG patterns of various ventricular arrhythmias<br><br>Ventricular tachycardia <br><br><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/097b95729fa14ac68da475ce6288a968x1088x570.JPEG\" alt=\"Explanation Image\"><br><br> <br><br>Polymorphic ventricular tachycardia associated with QTc prolongation- Torsades de pointes <br><br><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8ebe0b5757c4efca4f5dd15c6d24e99x1268x324.JPEG\" alt=\"Explanation Image\"><br><br> <br><br>Ventricular flutter <br><br><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/666962cd0f424000b7e84123f719f120x502x282.JPEG\" alt=\"Explanation Image\"><br><br> <br><br>Ventricular fibrillation <br><br><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/25067efa869941baa6a40b54599b371ax1049x213.PNG\" alt=\"Explanation Image\">",
      "explanation_video": "",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a0f394af1a0945e5bed9641fb2a6c188.JPEG"
      ],
      "explanation_images": []
    },
    {
      "text": "18. A patient being treated with itraconazole for histoplasmosis developed upper stomach discomfort. Consequently,  pantoprazole was also administered. Histoplasmosis treatment is continued, but his symptoms remain unchanged. Therapeutic failure is most likely due to?",
      "choices": [
        {
          "id": 1,
          "text": "Low pKa of Itraconazole and increased pH of stomach"
        },
        {
          "id": 2,
          "text": "Pantoprazole inhibition of CYP enzymes"
        },
        {
          "id": 3,
          "text": "Increased Volume of Distribution of Itraconazole"
        },
        {
          "id": 4,
          "text": "Pantoprazole displacing Itraconazole from plasma protein"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient, who is being treated with itraconazole for histoplasmosis with no resolution of symptoms, is having therapeutic failure due to reduced absorption/bioavailability of itraconazole. <br><br>Itraconazole is a drug with a low pKa and requires the acidity of the stomach for its absorption into the circulation. The addition of pantoprazole reduces the acidity of the stomach (pH increase), thus leading to increased ionization of itraconazole and reduced dissolution and absorption of the drug. Also, it is important to note pantoprazole has little effect on the CYP450 system.<br><br>pKa is defined as the pH at which a drug exists as 50% ionized (hydrophilic) and 50% unionized (lipophilic). For e.g., phenobarbitone is an acidic drug with a pKa of 7.2. At a pH of 7.2, 50% will be unionized. In a more basic plasma (pH=7.4), a lesser fraction (around 40%) will be unionized.<br><br>Small changes in pH near the pKa of a drug may cause large variations in the degree of ionization. When the pH = pKa of a drug, the concentration of the drug is 50% ionic and 50% non-ionic. <br><br>Other options:<br><br>Option B: Pantoprazole is minimally metabolised by CYP3A4(major by CYP2C19) whereas itraconazole is by CYP3A4. <br><br>Option C: Itraconazole is largely protein-bound, hence the volume of distribution would not be increased.<br><br>Option D: Pantoprazole cannot displace Itraconazole from its plasma protein site. Drugs that displace itraconazole from its protein binding site include warfarin and statins.",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "19. A chronic smoker was on nicotine replacement therapy and clonidine tablets for smoking de-addiction. He stopped taking clonidine tablets and now presents with a headache. Which of the following drugs is best suited for the treatment of his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Phenoxybenzamine"
        },
        {
          "id": 2,
          "text": "Prazosin"
        },
        {
          "id": 3,
          "text": "Phentolamine"
        },
        {
          "id": 4,
          "text": "Propranolol"
        }
      ],
      "correct_choice_id": 3,
      "solution": "The mechanism that causes headaches in this patient, who stopped taking clonidine, is rebound hypertension. Amongst the given drugs, phentolamine is best suited for the control of hypertension due to clonidine withdrawal.<br><br>Phentolamine is a non-selective alpha antagonist that opposes the alpha receptor-mediated vasoconstriction of sympathomimetics. It is also used in:<br><br>* Clonidine withdrawal<br><br>* Short-term control of hypertension in pheochromocytoma<br><br>* Limiting the duration of soft tissue anesthesia.<br><br>Clonidine is an alpha-2 receptor agonist and a centrally-acting antihypertensive agent. It treats high blood pressure by stimulating presynaptic α2 receptors in the vasomotor center in the brainstem. This binding has a sympatholytic effect, by suppressing the release of norepinephrine and other sympathomimetics.<br><br>Abrupt withdrawal after long-term therapy can result in rebound hypertension, restlessness, and sympathetic overactivity. Dry mouth and sedation are the major side effects of clonidine. It can also cause impotency and constipation. Phentolamine is used for the control of hypertension due to clonidine withdrawal.<br><br>Other options:<br><br>Option A: Phenoxybenzamine is also a non-selective alpha antagonist but has irreversible action. Side effects are postural hypotension, palpitation, nasal blockage, miosis, and inhibition of ejaculation. It is used primarily in pheochromocytoma, and occasionally in peripheral vascular disease.<br><br>Option B: Prazosin is a selective alpha-1 blocker. It is a potent antihyper­tensive but is not used as a first-line drug because fluid retention and tolerance gradually develop with monotherapy. Another major problem with prazosin is marked postural hypotension and syncope following the first dose (first dose effect).<br><br>Option D: Propranolol is a non-selective beta-blocker that decreases heart rate, force of contraction, and cardiac output. It reduces blood pressure on prolonged administration. It has mem­brane stabilizing (Na+ channel blocking) properties and is a potent local anesthetic. It also reduces the secretion of aqueous humor.",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "20. An 8-year-old girl presents with frequent episodes of staring spells in school. She is diagnosed with absence seizures. Which of the following is the mechanism of action of the drug of choice used for this condition?<br><br>GABA: gamma-aminobutyric acid",
      "choices": [
        {
          "id": 1,
          "text": "Sodium and calcium channel blockade"
        },
        {
          "id": 2,
          "text": "GABA uptake inhibition"
        },
        {
          "id": 3,
          "text": "GABA potentiation"
        },
        {
          "id": 4,
          "text": "Inhibition of the T-type calcium channels"
        }
      ],
      "correct_choice_id": 4,
      "solution": "Ethosuximide is the drug of choice for use in children suffering from absence seizures. Its mechanism of action is the inhibition of T-type calcium channels.<br><br>Absence seizures originate in the thalamus and produce the pathognomonic 3 Hz spike and wave pattern on EEG. This pattern is produced due to the intrinsic properties of the low threshold T-type calcium channels of the thalamus.<br><br>These channels are activated at a much lower threshold and produce larger currents as compared to most other calcium channels in the brain. Hence, inhibition of these T-type calcium currents in the neurons of the thalamus by ethosuximide is effective for the management of absence seizures.<br><br>Absence seizures are mostly seen in young school-going children. They present with briefly altered consciousness with staring spells often confused with daydreaming and declining performance in school by their parents and teachers.<br><br>These can be accompanied by rapid blinking or chewing motions. The episodes typically last for only 1-2 seconds, and the child regains consciousness immediately without any postictal confusion. Such episodes can occur up to 100 times per day. <br><br>Other options:<br><br>Option A: Valproate acts by blocking both calcium and sodium channels. It can be used in absence seizures, but it is preferred when the child also suffers from generalized tonic clonic seizures. It is the drug of choice for juvenile myoclonic epilepsy.<br><br>Option B: Vigabatrin acts as a GABA uptake inhibitor. It is the drug of choice for infantile spasms (West syndrome) seen in tuberous sclerosis.<br><br>Option C: Benzodiazepines act by promoting GABA inhibition by binding to the GABA receptor itself and inhibiting nerve transmission. Diazepam is used to prevent febrile seizures from recurring in children.<br><br>Pearl PM1695: First-line Agents in Different Types of Seizures<br><br><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure </strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures </p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine </li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS </td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate</li>\n<li aria-level=\"1\">Levetiracetam </li>\n<li aria-level=\"1\">Lamotrigine </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures </td>\n<td>\n<ul>\n<li><strong>Ethosuximide </strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\"1\">Lamotrigine</li>\n<li aria-level=\"1\">Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>Pearl PM2484: Mechanism of action of common anti-epileptics<br><br>Mechanism of action of some common antiepileptics:<br><br><table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine     </li>\n<li>Topiramate      </li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine   </li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A </sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br><br>Pearl PM1697: Important Adverse Effects of Anti-epileptic Drugs<br><br><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Antiepileptic drugs</strong></p>\n</td>\n<td>\n<p><strong>Adverse effects</strong></p>\n</td>\n</tr>\n<tr>\n<td>Carbamazepine</td>\n<td>Stevens-Johnson syndrome (SJS), diplopia, ataxia, hyponatremia</td>\n</tr>\n<tr>\n<td>Phenytoin</td>\n<td>Gum hyperplasia, hirsutism, osteomalacia, ataxia</td>\n</tr>\n<tr>\n<td>Valproic acid</td>\n<td>Hepatotoxicity, thrombocytopenia, transient alopecia, tremors, pancreatitis</td>\n</tr>\n<tr>\n<td>Phenobarbital</td>\n<td>Sedation, depression, ataxia, automatism</td>\n</tr>\n<tr>\n<td>Vigabatrin</td>\n<td>Loss of peripheral vision</td>\n</tr>\n<tr>\n<td>Felbamate</td>\n<td>Fulminant hepatic failure, aplastic anemia</td>\n</tr>\n<tr>\n<td>Lamotrigine</td>\n<td>Hypersensitivity reactions, SJS</td>\n</tr>\n<tr>\n<td>Topiramate</td>\n<td>Paresthesias, renal calculi, weight loss, acute glaucoma</td>\n</tr>\n<tr>\n<td>Oxcarbazepine</td>\n<td>Hyponatremia, SJS</td>\n</tr>\n<tr>\n<td>Ezogabine</td>\n<td>Urinary retention</td>\n</tr>\n<tr>\n<td>Zonisamide</td>\n<td>Renal calculi</td>\n</tr>\n<tr>\n<td>Perampanel</td>\n<td>Homicidal ideation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}